Implementation of Country-Wide Pharmacoeconomic Principles in Cancer Care in Developing Countries: Expert-Based Recommendations

Author:

Jazieh Abdul Rahman123,Pizzo Elena4,Gulacsi Laszlo5,Eldahiyat Faris6,Abu-Helalah Munir78,Ibrahim Nagwa9,AlAbdulkareem Hana110,Maraiki Fatma11,AlSaggabi Aabdulaziz110,Cornes Paul12

Affiliation:

1. King Abdullah International Medical Research Center, Riyadh, Saudi Arabia

2. College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia

3. Department of Oncology, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia

4. Department of Applied Health Research, University College London, London, United Kingdom

5. Department of Health Economics, Corvinus University Budapest, Budapest, Hungary

6. College of Pharmacy, Al Ain University, Al Ain, United Arab Emirates

7. College of Medicine, Alfaisal University, Riyadh, Saudi Arabia

8. Global Academy for Health Sciences, Cincinnati, Ohio, USA

9. Pharmacy Department, Prince Sultan Military Medical City, Riyadh, Saudi Arabia

10. Drug Policy and Economic Center, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia

11. Department of Pharmacy, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia

12. Comparative Outcomes Group, Bristol, United Kingdom

Abstract

Abstract Introduction: Cancer care is a major challenge to health care and for optimal outcomes, health systems need to align policy across many areas of public life. The recognition that even the wealthiest nations can fail optimum outcomes indicates a need for increased efficiency in cancer control programs. Fundamental to this is the efficient direction of resources––a process that can be optimized through economic measures. This article contains expert recommendations on how decision makers can implement pharmacoeconomic principles at national level in developing countries. Methods: A multidisciplinary panel of 10 experts was formed of oncologists, clinical pharmacists, health economists, and chronic disease control and public health experts from different countries and health-care sectors. The panel developed consensus recommendations for different stakeholders using a framework analysis method. Results: Recommendations were categorized as national level, hospital level, industry level, and public-community level to support decision makers in implementing pharmacoeconomic principles in a systematic way. The recommendations included having proper well-structured, data-driven processes with a specific role for each stakeholder. We proposed required structures and processes in such a way that they can be customized based on individual country plans. Conclusion: The expert panel recommendations will serve as a guide to relevant stakeholders at a national level. Adaptation of these recommendations to each setting is important to accommodate the situation and needs of each country.

Publisher

Innovative Healthcare Institute

Reference22 articles.

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3